{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:21:19Z","timestamp":1781896879683,"version":"3.54.5"},"reference-count":9,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:p> Laboratory research including animal models of human disease suggests that cannabinoids might have therapeutic potential in multiple sclerosis (MS). We have recently seen a 46-year-old woman who developed MS after starting treatment with a cannabino id recepto r antagonist for obesity. The occurrence of MS several months after starting a cannabinoid receptor antagonist suggests that the cannabino id system might indeed be relevant to disease pathogenesis in MS. <\/jats:p>","DOI":"10.1191\/1352458504ms1044oa","type":"journal-article","created":{"date-parts":[[2004,5,12]],"date-time":"2004-05-12T22:51:03Z","timestamp":1084402263000},"page":"330-332","source":"Crossref","is-referenced-by-count":25,"title":["Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist"],"prefix":"10.1177","volume":"10","author":[{"given":"B W","family":"van Oosten","sequence":"first","affiliation":[{"name":"Department of Neurology, VU University Medical Centre, P.O. Box 7057,                         1007 MB Amsterdam, the Netherlands,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Killestein","sequence":"additional","affiliation":[{"name":"Department of Neurology, VU University Medical Centre, P.O. Box 7057,                         1007 MB Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E MH","family":"Mathus-Vliegen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Academic Medical Centre,                         P.O. Box 22700, 1100 DE Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C H","family":"Polman","sequence":"additional","affiliation":[{"name":"Department of Neurology, VU University Medical Centre, P.O. Box 7057,                         1007 MB Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2004,6,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.9.1404"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14738-1"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1038\/35097089"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(98)01300-0"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1032"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg224"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.14.1763"},{"key":"atypb8","unstructured":"The Association of the British Pharmaceutical Industry, Target Schizophrenia.                 Accessed on-line 4 February, 2004, at: http:\/\/www.abpi.org.uk\/publications\/publication_details\/targetschizophrenia-2003\/section5.asp"},{"key":"atypb9","unstructured":"National Institutes of Health, ClinicalTrials.gov. Accessed on-line 4                 February, 2004, at: http:\/\/clinicaltrials.gov\/ct\/show\/NCT00075205?order=1"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1191\/1352458504ms1044oa","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1191\/1352458504ms1044oa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T18:06:47Z","timestamp":1740766007000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1191\/1352458504ms1044oa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1191\/1352458504ms1044oa"],"URL":"https:\/\/doi.org\/10.1191\/1352458504ms1044oa","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}